678 Disease control-related outcomes from an analysis of six comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone (LHRH) agonists

Autor:	B.E. Persson, Kurt Miller, N.D. Shore, E. Van Der Meulen, E.D. Crawford, Cathrina Karup
Rok vydání:	2013
Předmět:	Oncology medicine.medical_specialty Luteinising hormone releasing hormone business.industry Urology Disease control Clinical trial chemistry.chemical_compound Endocrinology chemistry Internal medicine medicine Degarelix business
Zdroj:	European Urology Supplements. 12:e678-e679
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(13)61160-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d15b49ea4045932847d4ca5e21955446 https://doi.org/10.1016/s1569-9056(13)61160-4 Zobrazit plný text záznamu Full Text from ScienceDirect